Neville Rodie & Shaw’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$963K Sell
10,500
-145
-1% -$12.7K 0.06% 134
2026
Q1
$907K Hold
10,645
0.07% 129
2025
Q4
$841K Hold
10,645
0.06% 138
2025
Q3
$851K Hold
10,645
0.06% 140
2025
Q2
$968K Sell
10,645
-1,130
-10% -$103K 0.07% 131
2025
Q1
$1.1M Sell
11,775
-355
-3% -$31.8K 0.09% 123
2024
Q4
$1.1M Hold
12,130
0.08% 125
2024
Q3
$1.26M Hold
12,130
0.09% 119
2024
Q2
$1.18M Hold
12,130
0.09% 120
2024
Q1
$1.09M Sell
12,130
-200
-2% -$16.9K 0.08% 128
2023
Q4
$983K Sell
12,330
-300
-2% -$22.6K 0.08% 131
2023
Q3
$898K Sell
12,630
-350
-3% -$26.2K 0.08% 130
2023
Q2
$1M Hold
12,980
0.09% 127
2023
Q1
$975K Sell
12,980
-58
-0.4% -$4.31K 0.09% 127
2022
Q4
$1.03M Hold
13,038
0.1% 121
2022
Q3
$916K Hold
13,038
0.09% 123
2022
Q2
$1.04M Hold
13,038
0.09% 120
2022
Q1
$996K Hold
13,038
0.07% 137
2021
Q4
$1.11M Hold
13,038
0.08% 137
2021
Q3
$986K Sell
13,038
-400
-3% -$31.8K 0.08% 135
2021
Q2
$1.09M Buy
13,438
+58
+0.4% +$4.74K 0.08% 129
2021
Q1
$1.05M Sell
13,380
-456
-3% -$35.7K 0.09% 128
2020
Q4
$1.18M Hold
13,836
0.1% 112
2020
Q3
$1.07M Hold
13,836
0.1% 113
2020
Q2
$1.01M Sell
13,836
-200
-1% -$14.2K 0.1% 112
2020
Q1
$932K Sell
14,036
-75
-0.5% -$5.29K 0.11% 113
2019
Q4
$972K Hold
14,111
0.1% 128
2019
Q3
$1.04M Hold
14,111
0.11% 120
2019
Q2
$1.01M Sell
14,111
-225
-2% -$16K 0.11% 124
2019
Q1
$983K Sell
14,336
-581
-4% -$37.5K 0.1% 123
2018
Q4
$888K Sell
14,917
-1,429
-9% -$89.4K 0.11% 124
2018
Q3
$1.09M Sell
16,346
-600
-4% -$40K 0.11% 121
2018
Q2
$1.1M Sell
16,946
-2,549
-13% -$167K 0.12% 122
2018
Q1
$1.4M Sell
19,495
-950
-5% -$68.4K 0.15% 109
2017
Q4
$1.54M Sell
20,445
-775
-4% -$56.6K 0.16% 107
2017
Q3
$1.55M Sell
21,220
-3,350
-14% -$241K 0.17% 103
2017
Q2
$1.82M Sell
24,570
-1,525
-6% -$113K 0.21% 96
2017
Q1
$1.91M Sell
26,095
-1,050
-4% -$73.5K 0.22% 90
2016
Q4
$1.78M Sell
27,145
-875
-3% -$60K 0.21% 92
2016
Q3
$2.08M Sell
28,020
-25
-0.1% -$1.85K 0.24% 93
2016
Q2
$2.05M Sell
28,045
-616
-2% -$43.9K 0.25% 93
2016
Q1
$2.02M Buy
28,661
+675
+2% +$44.9K 0.25% 90
2015
Q4
$1.86M Sell
27,986
-75
-0.3% -$4.99K 0.22% 91
2015
Q3
$1.78M Hold
28,061
0.22% 98
2015
Q2
$1.83M Sell
28,061
-331
-1% -$22.5K 0.2% 104
2015
Q1
$1.97M Sell
28,392
-3,025
-10% -$209K 0.2% 106
2014
Q4
$2.17M Buy
31,417
+900
+3% +$60.8K 0.22% 101
2014
Q3
$1.99M Sell
30,517
-76
-0.2% -$5.01K 0.2% 102
2014
Q2
$2.09M Sell
30,593
-200
-0.6% -$13.4K 0.21% 98
2014
Q1
$2M Sell
30,793
-39
-0.1% -$2.46K 0.22% 92
2013
Q4
$2.01M Sell
30,832
-4,275
-12% -$274K 0.22% 89
2013
Q3
$2.08M Buy
35,107
+25
+0.1% +$1.48K 0.24% 94
2013
Q2
$2.01M Buy
+35,082
New +$2.08M 0.24% 95

Other funds holding CL

Neville Rodie & Shaw's CL Position: Q2 2026 in Review

Neville Rodie & Shaw reduced its Colgate-Palmolive (CL) stake by 1.4% in Q2 2026, selling an estimated $12.7K and leaving 10,500 shares worth $963K. The position accounts for 0.06% of the portfolio, ranked #134.

Neville Rodie & Shaw first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.17M in Q4 2014. 623 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Neville Rodie & Shaw held 10,500 shares of Colgate-Palmolive worth $963K as of Q2 2026.
  • Neville Rodie & Shaw sold 145 Colgate-Palmolive shares in Q2 2026, an estimated $12.7K.
  • Colgate-Palmolive made up 0.06% of Neville Rodie & Shaw's portfolio in Q2 2026, its #134 holding.
  • Neville Rodie & Shaw first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Neville Rodie & Shaw's Colgate-Palmolive position peaked at $2.17M in Q4 2014.
  • 623 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.